- call +1-201-465-4211
- email sales@mrinsights.biz
Nonsterile drug compounding is the practice of preparing specific medication doses for patients to drink, swallow, insert or apply to the skin. It is the most common kind of drug compounding done by pharmacists and pharmacy technicians in community and hospital pharmacies. And despite its "nonsterile" designation, making customized dosages according to legal and professional standards requires adhering to strict rules for ensuring and maintaining active pharmaceutical ingredient purity and potency; ensuring the accuracy of mixing; providing proper packaging, storage, and labeling; and keeping all work surfaces and equipment as clean as possible.
Scope of the Report:
This report studies the Non-Sterile Compounding Pharmacy market status and outlook of Global and major regions, from angles of players, countries, product types and end industries; this report analyzes the top players in global market, and splits the Non-Sterile Compounding Pharmacy market by product type and applications/end industries.
Simple nonsterile compounding involves mixing medications according to established formulas, or "recipes," and creating liquid versions of drugs usually sold only as tablets or capsules. Pediatricians and veterinarians often request these kinds of products for babies and animals who cannot swallow pills or need doses smaller than ones in commercially produced products. Moderate nonsterile compounding involves making dosages containing potentially harmful medications or preparations that require special handling.
The global Non-Sterile Compounding Pharmacy market is valued at xx million USD in 2017 and is expected to reach xx million USD by the end of 2023, growing at a CAGR of xx% between 2017 and 2023.
The Asia-Pacific will occupy for more market share in following years, especially in China, also fast growing India and Southeast Asia regions.
North America, especially The United States, will still play an important role which cannot be ignored. Any changes from United States might affect the development trend of Non-Sterile Compounding Pharmacy.
Europe also play important roles in global market, with market size of xx million USD in 2017 and will be xx million USD in 2023, with a CAGR of xx%.
Market Segment by Companies, this report covers
Fagron
B.Braun Melsungen
Fresenius Kabi
True Nature Holding
Dougherty's Pharmacy
Pharmedium
Market Segment by Regions, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
South America (Brazil, Argentina, Colombia)
Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)
Market Segment by Type, covers
Oral Medication
Topical Medications
Otologic/Nasal Medication
Market Segment by Applications, can be divided into
Pain Management
Hormone Replacement Therapy
The base year for the study has been considered 2019, historic year 2014 and 2018, the forecast period considered is from 2020 to 2027. The regions analyzed for the market include North America, Europe, South America, Asia Pacific, and Middle East and Africa. These regions are further analyzed at the country-level. The study also includes attractiveness analysis of type, application and regions which are benchmarked based on their market size, growth rate and attractiveness in terms of present and future opportunity for understanding the future growth of the market.
Market is segmented on the basis:
The report offers in-depth analysis of driving factors, opportunities, restraints, and challenges for gaining the key insight of the market. The report emphasizes on all the key trends that play a vital role in the enlargement of the market from 2019 to 2026.
The report provides company profile of the key players operating in the market and a comparative analysis based on their business overviews industry offering, segment market share, regional presence, business strategies, innovations, mergers & acquisitions, recent developments, joint venture, collaborations, partnerships, SWOT analysis, and key financial information.
Table of Contents
1 Non-Sterile Compounding Pharmacy Market Overview
1.1 Product Overview and Scope of Non-Sterile Compounding Pharmacy
1.2 Classification of Non-Sterile Compounding Pharmacy by Types
1.2.1 Global Non-Sterile Compounding Pharmacy Revenue Comparison by Types (2017-2023)
1.2.2 Global Non-Sterile Compounding Pharmacy Revenue Market Share by Types in 2017
1.2.3 Oral Medication
1.2.4 Topical Medications
1.2.5 Otologic/Nasal Medication
1.3 Global Non-Sterile Compounding Pharmacy Market by Application
1.3.1 Global Non-Sterile Compounding Pharmacy Market Size and Market Share Comparison by Applications (2013-2023)
1.3.2 Pain Management
1.3.3 Hormone Replacement Therapy
1.4 Global Non-Sterile Compounding Pharmacy Market by Regions
1.4.1 Global Non-Sterile Compounding Pharmacy Market Size (Million USD) Comparison by Regions (2013-2023)
1.4.1 North America (USA, Canada and Mexico) Non-Sterile Compounding Pharmacy Status and Prospect (2013-2023)
1.4.2 Europe (Germany, France, UK, Russia and Italy) Non-Sterile Compounding Pharmacy Status and Prospect (2013-2023)
1.4.3 Asia-Pacific (China, Japan, Korea, India and Southeast Asia) Non-Sterile Compounding Pharmacy Status and Prospect (2013-2023)
1.4.4 South America (Brazil, Argentina, Colombia) Non-Sterile Compounding Pharmacy Status and Prospect (2013-2023)
1.4.5 Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa) Non-Sterile Compounding Pharmacy Status and Prospect (2013-2023)
1.5 Global Market Size of Non-Sterile Compounding Pharmacy (2013-2023)
2 Manufacturers Profiles
2.1 Fagron
2.1.1 Business Overview
2.1.2 Non-Sterile Compounding Pharmacy Type and Applications
2.1.2.1 Product A
2.1.2.2 Product B
2.1.3 Fagron Non-Sterile Compounding Pharmacy Revenue, Gross Margin and Market Share (2016-2017)
2.2 B.Braun Melsungen
2.2.1 Business Overview
2.2.2 Non-Sterile Compounding Pharmacy Type and Applications
2.2.2.1 Product A
2.2.2.2 Product B
2.2.3 B.Braun Melsungen Non-Sterile Compounding Pharmacy Revenue, Gross Margin and Market Share (2016-2017)
2.3 Fresenius Kabi
2.3.1 Business Overview
2.3.2 Non-Sterile Compounding Pharmacy Type and Applications
2.3.2.1 Product A
2.3.2.2 Product B
2.3.3 Fresenius Kabi Non-Sterile Compounding Pharmacy Revenue, Gross Margin and Market Share (2016-2017)
2.4 True Nature Holding
2.4.1 Business Overview
2.4.2 Non-Sterile Compounding Pharmacy Type and Applications
2.4.2.1 Product A
2.4.2.2 Product B
2.4.3 True Nature Holding Non-Sterile Compounding Pharmacy Revenue, Gross Margin and Market Share (2016-2017)
2.5 Dougherty's Pharmacy
2.5.1 Business Overview
2.5.2 Non-Sterile Compounding Pharmacy Type and Applications
2.5.2.1 Product A
2.5.2.2 Product B
2.5.3 Dougherty's Pharmacy Non-Sterile Compounding Pharmacy Revenue, Gross Margin and Market Share (2016-2017)
2.6 Pharmedium
2.6.1 Business Overview
2.6.2 Non-Sterile Compounding Pharmacy Type and Applications
2.6.2.1 Product A
2.6.2.2 Product B
2.6.3 Pharmedium Non-Sterile Compounding Pharmacy Revenue, Gross Margin and Market Share (2016-2017)
3 Global Non-Sterile Compounding Pharmacy Market Competition, by Players
3.1 Global Non-Sterile Compounding Pharmacy Revenue and Share by Players (2013-2018)
3.2 Market Concentration Rate
3.2.1 Top 5 Non-Sterile Compounding Pharmacy Players Market Share
3.2.2 Top 10 Non-Sterile Compounding Pharmacy Players Market Share
3.3 Market Competition Trend
4 Global Non-Sterile Compounding Pharmacy Market Size by Regions
4.1 Global Non-Sterile Compounding Pharmacy Revenue and Market Share by Regions
4.2 North America Non-Sterile Compounding Pharmacy Revenue and Growth Rate (2013-2018)
4.3 Europe Non-Sterile Compounding Pharmacy Revenue and Growth Rate (2013-2018)
4.4 Asia-Pacific Non-Sterile Compounding Pharmacy Revenue and Growth Rate (2013-2018)
4.5 South America Non-Sterile Compounding Pharmacy Revenue and Growth Rate (2013-2018)
4.6 Middle East and Africa Non-Sterile Compounding Pharmacy Revenue and Growth Rate (2013-2018)
5 North America Non-Sterile Compounding Pharmacy Revenue by Countries
5.1 North America Non-Sterile Compounding Pharmacy Revenue by Countries (2013-2018)
5.2 USA Non-Sterile Compounding Pharmacy Revenue and Growth Rate (2013-2018)
5.3 Canada Non-Sterile Compounding Pharmacy Revenue and Growth Rate (2013-2018)
5.4 Mexico Non-Sterile Compounding Pharmacy Revenue and Growth Rate (2013-2018)
6 Europe Non-Sterile Compounding Pharmacy Revenue by Countries
6.1 Europe Non-Sterile Compounding Pharmacy Revenue by Countries (2013-2018)
6.2 Germany Non-Sterile Compounding Pharmacy Revenue and Growth Rate (2013-2018)
6.3 UK Non-Sterile Compounding Pharmacy Revenue and Growth Rate (2013-2018)
6.4 France Non-Sterile Compounding Pharmacy Revenue and Growth Rate (2013-2018)
6.5 Russia Non-Sterile Compounding Pharmacy Revenue and Growth Rate (2013-2018)
6.6 Italy Non-Sterile Compounding Pharmacy Revenue and Growth Rate (2013-2018)
7 Asia-Pacific Non-Sterile Compounding Pharmacy Revenue by Countries
7.1 Asia-Pacific Non-Sterile Compounding Pharmacy Revenue by Countries (2013-2018)
7.2 China Non-Sterile Compounding Pharmacy Revenue and Growth Rate (2013-2018)
7.3 Japan Non-Sterile Compounding Pharmacy Revenue and Growth Rate (2013-2018)
7.4 Korea Non-Sterile Compounding Pharmacy Revenue and Growth Rate (2013-2018)
7.5 India Non-Sterile Compounding Pharmacy Revenue and Growth Rate (2013-2018)
7.6 Southeast Asia Non-Sterile Compounding Pharmacy Revenue and Growth Rate (2013-2018)
8 South America Non-Sterile Compounding Pharmacy Revenue by Countries
8.1 South America Non-Sterile Compounding Pharmacy Revenue by Countries (2013-2018)
8.2 Brazil Non-Sterile Compounding Pharmacy Revenue and Growth Rate (2013-2018)
8.3 Argentina Non-Sterile Compounding Pharmacy Revenue and Growth Rate (2013-2018)
8.4 Colombia Non-Sterile Compounding Pharmacy Revenue and Growth Rate (2013-2018)
9 Middle East and Africa Revenue Non-Sterile Compounding Pharmacy by Countries
9.1 Middle East and Africa Non-Sterile Compounding Pharmacy Revenue by Countries (2013-2018)
9.2 Saudi Arabia Non-Sterile Compounding Pharmacy Revenue and Growth Rate (2013-2018)
9.3 UAE Non-Sterile Compounding Pharmacy Revenue and Growth Rate (2013-2018)
9.4 Egypt Non-Sterile Compounding Pharmacy Revenue and Growth Rate (2013-2018)
9.5 Nigeria Non-Sterile Compounding Pharmacy Revenue and Growth Rate (2013-2018)
9.6 South Africa Non-Sterile Compounding Pharmacy Revenue and Growth Rate (2013-2018)
10 Global Non-Sterile Compounding Pharmacy Market Segment by Type
10.1 Global Non-Sterile Compounding Pharmacy Revenue and Market Share by Type (2013-2018)
10.2 Global Non-Sterile Compounding Pharmacy Market Forecast by Type (2018-2023)
10.3 Oral Medication Revenue Growth Rate (2013-2023)
10.4 Topical Medications Revenue Growth Rate (2013-2023)
10.5 Otologic/Nasal Medication Revenue Growth Rate (2013-2023)
11 Global Non-Sterile Compounding Pharmacy Market Segment by Application
11.1 Global Non-Sterile Compounding Pharmacy Revenue Market Share by Application (2013-2018)
11.2 Non-Sterile Compounding Pharmacy Market Forecast by Application (2018-2023)
11.3 Pain Management Revenue Growth (2013-2018)
11.4 Hormone Replacement Therapy Revenue Growth (2013-2018)
12 Global Non-Sterile Compounding Pharmacy Market Size Forecast (2018-2023)
12.1 Global Non-Sterile Compounding Pharmacy Market Size Forecast (2018-2023)
12.2 Global Non-Sterile Compounding Pharmacy Market Forecast by Regions (2018-2023)
12.3 North America Non-Sterile Compounding Pharmacy Revenue Market Forecast (2018-2023)
12.4 Europe Non-Sterile Compounding Pharmacy Revenue Market Forecast (2018-2023)
12.5 Asia-Pacific Non-Sterile Compounding Pharmacy Revenue Market Forecast (2018-2023)
12.6 South America Non-Sterile Compounding Pharmacy Revenue Market Forecast (2018-2023)
12.7 Middle East and Africa Non-Sterile Compounding Pharmacy Revenue Market Forecast (2018-2023)
13 Research Findings and Conclusion
14 Appendix
14.1 Methodology
14.2 Data Source
List of Tables and Figures
Figure Non-Sterile Compounding Pharmacy Picture
Table Product Specifications of Non-Sterile Compounding Pharmacy
Table Global Non-Sterile Compounding Pharmacy and Revenue (
ProactiveWe manage our resources 24/7 to identify issues and address them before they become problems
Quality & ReliabilityWe are committed to providing reliable and highly accurate data with an excellent quality control system
Global Outreach6 Major regions and 40+ countries level analysis accomplished
Competitive PricingOur pricing strategy is highly competitive in the market, without compensating on the quality and the timeline of project delivery
